Vivo Bio Tech Ltd (VIVOBIOT)

Loading page…

Vivo Bio Tech Ltd (VIVOBIOT) · mywealthgrid

About

Vivo Bio Tech Ltd operates in Biotechnology within the Healthcare sector.

Face value: ₹10

Market cap

₹38 Cr

P/E

5.2×

P/B

0.5×

Dividend yield

ROE

11%

ROCE

15.2%

Debt / equity

0.69

OPM

44%

EPS (TTM)

₹3.3

Book value

₹35.1

52-week high

—

52-week low

—

2,356 historical price candles were omitted because the exchange source has not been verified.

₹17.1+0.5%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 44%
+Profit CAGR of 49% over the last 3 years

Cons

−Low return on equity of 7% (3-yr avg)
−Revenue shrank over the last 3 years (-3.2% a year)
−Promoter holding fell 8.4 pts over the last year

Research score

Structured signal from quality, growth, valuation and momentum.

65/100

Business quality: 46
Growth: 50
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	52	51	52	45	47
COGS	7	11	7	4	6
Gross profit	45	40	45	42	41
	27	24	24	21	20
Operating profit (EBITDA)	18	16	22	21	21
OPM %	34.1%	30.8%	41.2%	46.4%	44%
Depreciation	6	7	9	9	9
Interest	4	4	8	8	8
	0	0	0	0	5
Profit before tax	9	4	5	4	9
Tax	3	2	2	2	2
Tax %	34.1%	50.8%	42.6%	37.7%	17.2%
	6	2	3	3	7
PAT margin %	11%	4.3%	5.1%	5.6%	15.6%
EPS (₹)	—	—	—	—	—
EPS adjusted (₹)	4.2	1.5	1.8	1.7	4.2
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity capital	13	14	15	15	17
Reserves	29	33	37	40	61
Minority interest	—	0	—	—	—
	31	67	62	73	54
	6	8	9	10	11
Total equity & liabilities	80	122	123	137	143
	52	95	89	80	88
CWIP	0	1	2	9	13
Investments	0	0	0	0	0
	27	26	32	48	42
Total assets	80	122	123	137	143

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	14	17	15	16	12
	-23	-51	-4	-8	-16
	9	35	-11	-8	4
Net cash flow	0	1	-0	0	-0
Free cash flow	-9	-34	11	8	-10
CFO / Operating profit %	80.3%	105.3%	69%	73.6%	57.7%

Compounded sales growth

7 years: —
5 years: —
3 years: -3%
1 year: 3%

Compounded profit growth

7 years: —
5 years: —
3 years: 49%
1 year: 188%

Return on equity

7 years: —
5 years: 7%
3 years: 6%
Last year: 9%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Margins
Gross margin %	86.1%	77.7%	87%	91.5%	87.6%
EBITDA margin %

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	42.08%	42.08%	42.08%	42.08%	42.08%	38.88%	40.85%	39.06%	35.16%	35.16%	35.43%	30.62%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	57.92%	57.92%	57.92%	57.92%	57.92%	61.12%	59.15%	60.94%	64.84%	64.84%	64.57%	69.38%
No. of shareholders	—	—	—	—	—	—	—	—	21,647	21,622	21,427	21,225

Promoter holding down 11.46 percentage points since Sep 2023.

19 deals · 13 Oct 2021 – 8 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
8 Jun 2026	SHRI SHRI RESORTS PVT LTD	Bulk	BSE	Sell	10,00,000	₹24.23	₹2.42 Cr
8 Jun 2026	MORE AGRISUPPLIES & SERVICES PRIVATE LIMITED	Bulk	BSE	Buy	6,99,248	₹24.28	₹1.70 Cr
8 Jun 2026	VEAN SMART INFRA PRIVATE LIMITED	Bulk	BSE	Buy	2,94,000	₹24.12	₹0.71 Cr
16 Sept 2025	MAHESH RATHORE	Bulk	BSE	Sell	1,08,000	₹38.00	₹0.41 Cr
14 May 2025	MALLEMKONDA REALITIES PVT	Bulk	BSE	Sell	2,06,395	₹41.20	₹0.85 Cr
13 May 2025	MALLEMKONDA REALITIES PVT	Bulk	BSE	Sell	94,307	₹40.27	₹0.38 Cr
22 Jan 2025	SUDHIRKUMAR	Bulk	BSE	Sell	1,03,102	₹56.18	₹0.58 Cr
22 Jan 2025	SUDHIRKUMAR	Bulk	BSE	Buy	1,03,102	₹55.26	₹0.57 Cr
3 Jan 2025	EVERY WEAR IMPORT AND EXPORT PRIVATE LIMITED	Bulk	BSE	Sell	2,37,448	₹41.61	₹0.99 Cr
6 Dec 2024	VEAN SMART INFRA PRIVATE LIMITED	Bulk	BSE	Sell	81,421	₹37.51	₹0.31 Cr

1–10 of 19

1 / 2

Mrs. PRIYA RAJENDER GODANon-Executive - Independent Director-Chairperson
Mr. SRI KALYAN KOMPELLAExecutive Director
Mr. SANKARANARAYANAN ALANGUDIExecutive Director
Mr. KALYAN RAM MANGIPUDIExecutive Director
Mr. SATYANARAYANA VEDULANon-Executive - Non Independent Director
Mr. SHYAM SUNDER TIPPARAJUNon-Executive - Independent Director
Mr. Bhavish VijayvargiyaCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Vivo Bio Tech Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results13 Jul 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

25 announcementsExport CSV

26 Aug 2026, 6:23 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

Loading announcements…

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Margins
Gross margin %	86.1%	77.7%	87%	91.5%	87.6%
EBITDA margin %

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Anthem Biosciences LimitedANTHEMANTHEM	₹48,213 Cr	₹48,264 Cr	₹2,002 Cr	₹793 Cr	39.3%	₹576 Cr	27.9%	27.6%	19.5%	124
Advanced Enzyme Technologies LimitedADVENZYMESADVENZYMES	₹3,072 Cr	₹3,092 Cr	₹750 Cr	₹224 Cr	30.7%	₹166 Cr	23.3%	13.7%	11.1%	331
CCME Global LtdCCMECCME	₹54 Cr	₹54 Cr	₹0 Cr	₹0 Cr	—	₹4 Cr	—	-2.9%	-2.9%	—
Vivo Bio Tech LtdVIVOBIOTVIVOBIOT	₹38 Cr	₹92 Cr	₹47 Cr	₹21 Cr	44%	₹7 Cr	15.6%	15.2%	11%	517
Shree Ganesh Biotech (India) LtdSHREEGANESSHREEGANES	₹19 Cr	₹19 Cr	₹23 Cr	₹-1 Cr	-19.3%	₹0 Cr	7.7%	0.8%	0.6%	846
Genomic Valley Biotech LtdGVBLGVBL	₹9 Cr	₹9 Cr	₹0 Cr	₹-0 Cr	14.8%	₹-1 Cr	11.1%	1%	0.8%	3,565

Date	Category	Subject	Filing
26 Aug 2026, 6:23 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
24 Aug 2026, 7:23 pm	Company Update General	Expiry Of Warrants	PDF
24 Aug 2026, 10:16 am	Insider Trading / SAST Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	PDF
24 Aug 2026, 10:14 am	Insider Trading / SAST Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	PDF
24 Aug 2026, 10:13 am	Insider Trading / SAST Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	PDF
22 Aug 2026, 7:43 pm	Company Update Change in Management	Announcement under Regulation 30 (LODR)-Change in Management	PDF
22 Aug 2026, 7:40 pm	Others Outcome without intimation	Board Meeting Outcome for Outcome Of Board Meeting	PDF
21 Aug 2026, 7:04 pm	Company Update General	Expiry Of Warrants	PDF

Leverage
Current ratio	1.24	1.12	1.27	1.25	1.51

Return ratios
Return on assets %	7.1%	1.8%	2.2%	1.8%	5.1%

Working capital
Receivable days	51	85	87	95	88

Vivo Bio Tech Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Board meetings1

Announcements

Not in the F&O segment

No fund holdings on record

Board meetings1

Quarterly record

Bulk & block deals

Board and management

Announcements

Ratio timeline

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1